Dental Care News
-
Creative Enzymes Launches Revolutionary Enzyme for Toothpaste to Improve Oral Health
Creative Enzymes, a professional enzyme provider located in New York, USA, is always hammering away at research and trials in order to provide customers with enzyme services and products with its greatest effort. Just a while ago, the company launched a new enzyme for toothpaste that is revolutionizing oral health. Oral hygiene is a critical aspect of daily life, with many people prioritizing ...
-
Apex Dental Sensors Work With Cloud9 Software
Do you have Cloud9 Software? Don’t want to switch your imaging software? Apex Dental Sensors are nearly 1/2 the cost of our major competitors & work with Cloud9 Software. https://www.youtube.com/watch?v=MKdj1RU9b-U You don’t have to worry about sacrificing imaging quality either. At a theoretical 25 line pair/mm the Apex Dental Sensors offer High Resolution Image Quality. ...
-
Apex Dental Sensors Work With Progeny Software
Do you have Progeny Software? Don't want to switch your imaging software? Apex Dental Sensors are nearly 1/2 the cost of our major competitors & work with Progeny Software. You don’t have to worry about sacrificing imaging quality either. At a theoretical 25 line pair/mm the Apex Dental Sensors offer High Resolution Image Quality. Thanks to our rigorous design and testing all Apex ...
-
RevBio Receives Approval from the U.K.’s Regulatory Authority to Initiate a Clinical Trial for an Optimized Formulation of its Dental Bone Adhesive Biomaterial
RevBio, Inc., announced that it has received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom to start a 15-patient clinical trial to examine the safety and efficacy of immediately stabilized dental implants following tooth extractions using an optimized formulation of Tetranite®, the company’s bone adhesive biomaterial. Dr. Michael R. Norton, ...
By RevBio Inc.
-
A Guide to Dental Oral Surgeries
Oral surgeons have the skillset and the technology to transform their patients’ mouths. From relatively simple tasks like removing impacted teeth to life-saving measures like removing oral cancer, these highly skilled professionals are trained to rescue their patients in their time of need. There’s more than one way to get your teeth worked on. Dental surgeries come in many ...
-
Bone Therapeutics signs definitive subscription agreement for a maximum of EUR 5M convertible bonds facility with ABO
BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics, today announces that it has signed the definitive subscription agreement for a maximum EUR 5 million convertible bonds (CBs) facility arranged by ABO Securities, through its affiliated entity Global Tech Opportunities 15. The proceeds of the financing will contribute to ...
-
Bone Therapeutics enters into exclusive reverse merger discussions with Medsenic
BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases, today announces it has entered into a non-binding term sheet and exclusive discussions for a period of three months with the shareholders of Medsenic, a privately held, clinical stage biopharmaceutical company incorporated in France and specialized in ...
-
Bone Therapeutics to host Annual General Meeting and Extraordinary General Meeting on 8 June 2022
BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics, invites its shareholders and the holders of registered subscription rights and registered convertible bonds of the Company to the Annual General Meeting to be held on Wednesday 8 June 2022 as from 4:00 pm CEST, at Rue Granbonpré 11, Building H, 1435 ...
-
Transparency notification received from Nyenburgh Holding NV
BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases, today announces that it has received a transparency notification dated 16 March 2022 indicating that the shareholdings held by Nyenburgh Holding NV have crossed below the minimum threshold of 5%. The notification dated 16 March 2022 contains the ...
-
Align Technology Continues to Revolutionize Orthodontic and Restorative Dental Treatment Planning With Invisalign System Innovations For the Align Digital Platform That Enhance Practice Efficiency, Doctor-Patient Engagement, and Treatment Outcomes
ClinCheck Live Update for 3D controls enables real-time ClinCheck treatment plan modifications that improve practice productivity significantly, while also improving quality of treatment plans Invisalign Practice App provides mobile integration with the Invisalign Doctor Site (IDS) and enables doctors to manage their practice at their fingertips. Invisalign Personalized Plan (IPP) ...
-
Bone Therapeutics announces closing of private placement
BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases, today announces the closing of the private placement announced on 3 December 2021, with existing and new institutional investors having purchased 4,832,352 new shares at an issue price of EUR 0.68 per share resulting in gross proceeds of approximately ...
-
Newster Weidun at China International Import Expo 2021
Newster Weidun participated at the fourth edition of China International Import Expo (CIIE), one of the most important Chinese import-themed professional trade fairs dedicated to the import of products and services of foreign exhibitors, held from November 5 to 10 at the National Exhibition and Convention Centre in Shanghai. The exhibition, organized by the Ministry of Commerce of the ...
-
Align Technology to Award Research Programs Advancing Orthodontic and Dental Patient Care
TEMPE, Ariz., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) today announced the opening of its 2022 Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $375,000 will be awarded to university faculty for scientific and technological research initiatives to advance patient care in the fields of ...
-
CytoSorbents Announces Availability of Preliminary Data Abstracts from Two Endocarditis Studies, including the REMOVE study, to be Presented at the EACTS Conference
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification, announced the public availability of preliminary data abstracts from two separate endocarditis studies, including the REMOVE study, to be presented at the upcoming European Association for Cardio-Thoracic Surgery (EACTS) annual meeting ...
-
IEG Is ready to re-start with expos and conferences: authentic relief for companies´ business
Italian Exhibition Group, key international expo and conference player, with its Rimini and Vicenza expo venues and listed on the screen-based share market (MTA) organized and managed by Borsa Italiana SpA, is facing the world emergency by making rapid choices in Italy and abroad. IEG President Lorenzo Cagnoni says, ´Fundamental strategic choices made to keep the engines running, now ready ...
-
Navident obtains regulatory approvals for guiding root canal treatment
ClaroNav announced today that it has obtained Health Canada and CE Mark approvals to expand the indications for use of its dental navigation system, Navident, to include guiding any dental procedure. In the past, Navident, like other dental navigation systems, was limited for use in guiding the placement of dental implants. This is the first time a dental dynamic navigation system has been ...
By ClaroNav
-
LaunchPad Medical Wins a Coveted $1.8 Million Michigan-Pittsburgh-Wyss Regenerative Medicine Center Grant
LaunchPad Medical, Inc. announced that it has received follow-on support of up to $1.8 million from the Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center which was funded by the National Institute of Dental and Cranial Research (U24-DE029462) to improve the translation of promising tissue engineering and regenerative medicine technologies for dental, oral, and craniofacial clinical ...
By RevBio Inc.
-
Planmeca and Navigate Surgical Technologies Join Forces to Launch Innovative Solutions for Dental Im
Dental manufacturer Planmeca and Navigate Surgical Technologies (NST), a provider of real-time surgical navigation solutions, are pleased to announce their cooperation. This partnership aims to provide dental implant surgeons with technological innovations that will deliver enhanced patient outcomes through improved accuracy and precision, as well as through simplified digital workflows. Dynamic ...
-
Countdown to GC`s 100th Anniversary!
GC will be celebrating its 100th anniversary in 2021. For the purpose of communicating to all societies its slogan of “Smile for the World” toward the realization of “Vision 2021”, targeting at the year of 2021, GC had designed a symbol in February 2017 to convey the concept of “GC Contributing to Health and Smile of People in the World”. On this occasion, GC ...
-
American Dental Association Pleased With UNEP Treaty Outcomes
The American Dental Association (ADA) is very pleased by the agreed upon provisions related to dental amalgam included in the United Nations Environment Program proposed mercury treaty. Delegates from more than 130 countries gathered in Geneva to develop the global treaty aimed at limiting emissions. Burning of coal is the largest single manmade source of mercury in the environment. The treaty ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you